Search
Search
Yuxi Zheng, MD
Show Description +
Dr. Zheng discusses the clinical signs of regression in eyes treated with intravitreal bevacizumab for type 1 retinopathy of prematurity.
Posted: 8/07/2025
Next Generation Meeting Coverage
Hear from the next generation of residents and fellows in ophthalmology.
Yuxi Zheng, MD
Dr. Zheng discusses the clinical signs of regression in eyes treated with intravitreal bevacizumab for type 1 retinopathy of prematurity.
Posted: 8/07/2025
Next Generation Meeting Coverage
Hear from the next generation of residents and fellows in ophthalmology.
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of Next Generation Meeting Coverage: ASRS.
Please log in to leave a comment.